Literature DB >> 12201041

Apoptotic chondrocyte death in cell-matrix biocomposites used in autologous chondrocyte transplantation.

Justus Gille1, Eva-M Ehlers, Mathias Okroi, Martin Russlies, Peter Behrens.   

Abstract

Tissue engineering may be a promising approach for the treatment of focal articular cartilage defects. Programmed cell death (apoptosis) plays an important role in multiple degenerative processes of cartilage (e.g. osteoarthritis). It is known that matrix provides a trophic signal for the cells and an altered matrix may influence the availability of factors that regulate apoptosis. In this study we investigate the viability of chondrocytes seeded on a Chondrogide scaffold (Geistlich Biomaterials, CH), which we use in matrix-induced autologous chondrocyte transplantation (MACT). By now, we have studied material from 29 patients treated for localized articular cartilage defects in the knee. Our results indicate that light microscopy (Mayer's hematoxylin-eosin, Masson-Goldner, Trypan-blue and TUNEL method) and electron microscopy can be used to investigate for apoptotic cells grown on a Chondrogide resorbable scaffold. Neither the handling of the cell-matrix biocomposite nor the procedures for fixation could destroy the scaffold or the cell sheet adhering firmly to the matrix. Apoptotic cells were revealed in all samples and with all techniques used. Mayer's hematoxylin-eosin and Masson-Goldner staining show cells with a condensed, pycnotic nucleus and shrunken cytoplasm. In electron microscopy we observed cells with chromatin condensation and volume shrinkage consistent with apoptosis. The results of the Trypan-blue staining show a mean viability of 92.1 +/- 9.8% (range 57-100%). The TUNEL method revealed 44.6 +/- 20.4% positive cells. Our results indicate that apoptosis plays an important role in chondrocytes grown on a scaffold. An optimal scaffold will determine the growth, morphology and phenotype of the chondrocytes by its physical and chemical characteristics.

Entities:  

Mesh:

Year:  2002        PMID: 12201041     DOI: 10.1016/S0940-9602(02)80047-4

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  6 in total

1.  Analysis of the autologous chondrocyte quality of matrix-based autologous chondrocyte implantation in the knee joint.

Authors:  Thomas R Niethammer; Kerstin Limbrunner; Oliver B Betz; Mehmet F Gülecyüz; Matthias F Pietschmann; Markus Feist; Peter E Müller
Journal:  Int Orthop       Date:  2015-06-25       Impact factor: 3.075

2.  Contact pressures at grafted cartilage lesions in the knee.

Authors:  Manuela T Raimondi; Riccardo Pietrabissa
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-10-16       Impact factor: 4.342

3.  Cell-Laden and Cell-Free Matrix-Induced Chondrogenesis versus Microfracture for the Treatment of Articular Cartilage Defects: A Histological and Biomechanical Study in Sheep.

Authors:  Justus Gille; Julius Kunow; Luer Boisch; Peter Behrens; Ingeborg Bos; Christiane Hoffmann; Wolfgang Köller; Martin Russlies; Bodo Kurz
Journal:  Cartilage       Date:  2010-01       Impact factor: 4.634

4.  Autologous Matrix-Induced Chondrogenesis (AMIC): Combining Microfracturing and a Collagen I/III Matrix for Articular Cartilage Resurfacing.

Authors:  J P Benthien; P Behrens
Journal:  Cartilage       Date:  2010-01       Impact factor: 4.634

Review 5.  Major biological obstacles for persistent cell-based regeneration of articular cartilage.

Authors:  Andre F Steinert; Steven C Ghivizzani; Axel Rethwilm; Rocky S Tuan; Christopher H Evans; Ulrich Nöth
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 6.  Chondrogenic differentiation of human adipose-derived stem cells: a new path in articular cartilage defect management?

Authors:  Jan-Philipp Stromps; Nora Emilie Paul; Björn Rath; Mahtab Nourbakhsh; Jürgen Bernhagen; Norbert Pallua
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.